SH3TC2 and Charcot-Marie-Tooth disease: In a Southern Italy study, the prevalence of SH3TC2 in overall CMT population was 3.2%, but it raised at 11.6% in sporadic demyelinating CMT cohort (SH3TC2 represents the second prevalent gene in this selected population) (15).